Versant Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.95K Sell
328
-3,007
-90% -$52.5K ﹤0.01% 2434
2026
Q1
$63.9K Buy
3,335
+2,958
+785% +$64.3K 0.01% 1090
2025
Q4
$8.29K Buy
377
+49
+15% +$884 ﹤0.01% 2076
2025
Q3
$3.98K Sell
328
-1,728
-84% -$23.4K ﹤0.01% 2292
2025
Q2
$38.3K Buy
2,056
+1,284
+166% +$25.4K 0.01% 1132
2025
Q1
$14.8K Buy
772
+188
+32% +$5.5K ﹤0.01% 1508
2024
Q4
$21K Buy
584
+207
+55% +$7K ﹤0.01% 1009
2024
Q3
$16K Hold
377
﹤0.01% 878
2024
Q2
$15.2K Hold
377
﹤0.01% 810
2024
Q1
$13.3K Hold
377
﹤0.01% 647
2023
Q4
$11.2K Buy
377
+370
+5,286% +$7.68K ﹤0.01% 705
2023
Q3
$145 Sell
7
-35
-83% -$961 ﹤0.01% 1906
2023
Q2
$1.03K Sell
42
-476
-92% -$15.3K ﹤0.01% 1590
2023
Q1
$21K Buy
+518
New +$21.4K 0.01% 470
2022
Q2
Sell
-4
Closed 1641
2022
Q1
$0 Hold
4
﹤0.01% 1626
2021
Q4
$1K Hold
4
﹤0.01% 1359
2021
Q3
$0 Hold
4
﹤0.01% 1599
2021
Q2
$0 Hold
4
﹤0.01% 1595
2021
Q1
$0 Hold
4
﹤0.01% 1603
2020
Q4
$0 Hold
4
﹤0.01% 1525
2020
Q3
$0 Hold
4
﹤0.01% 1497
2020
Q2
$0 Hold
4
﹤0.01% 1540
2020
Q1
$0 Sell
4
-7
-64% -$490 ﹤0.01% 1660
2019
Q4
$0 Hold
11
﹤0.01% 1575
2019
Q3
$0 Buy
+11
New +$702 ﹤0.01% 1586
2019
Q2
Sell
-9
Closed 1693
2019
Q1
$0 Buy
+9
New +$473 ﹤0.01% 1734

Other funds holding TNDM

Versant Capital Management's TNDM Position: Q2 2026 in Review

Versant Capital Management reduced its Tandem Diabetes Care (TNDM) stake by 90% in Q2 2026, selling an estimated $52.5K and leaving 328 shares worth $4.95K. The position accounts for ﹤0.01% of the portfolio, ranked #2434.

Versant Capital Management first reported a position in TNDM in Q1 2019 and has held it in 26 quarters since. The position peaked at $63.9K in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Versant Capital Management held 328 shares of Tandem Diabetes Care worth $4.95K as of Q2 2026.
  • Versant Capital Management sold 3,007 Tandem Diabetes Care shares in Q2 2026, an estimated $52.5K.
  • Tandem Diabetes Care made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2434 holding.
  • Versant Capital Management first reported a position in Tandem Diabetes Care in Q1 2019 and has held it in 26 quarters since.
  • Versant Capital Management's Tandem Diabetes Care position peaked at $63.9K in Q1 2026.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.